Nexus Medical is a prominent player in the Health Care and Manufacturing industries, specializing in IV Therapy Solutions. The company's flagship invention, the TKO Anti-Reflux Needleless Connector, has been proven effective in maintaining 24/7 IV Patency through extensive laboratory and clinical validation. Founded in 2001, Nexus Medical emerged after securing a grant from the US Army Medical Material Command in Fort Detrick, Maryland, to address IV catheter failures among Warfighters. Their breakthrough technology, TKO, a 3-position pressure-activated silicone diaphragm, has received FDA clearance and stands as a testament to their commitment to patient safety, prolonged catheter life, improved clinical outcomes, enhanced patient satisfaction, and reduced costs.
Furthermore, Nexus Medical offers a comprehensive range of infusion connectors and sets, extending their impact beyond just the TKO Anti-Reflux Needleless Connector. While the company has not disclosed its last investment or the identity of the last investment investors, its continuous innovation and pursuit of excellence make it an intriguing prospect for potential investors seeking opportunities in the healthcare and manufacturing sectors.
For more updates, interested parties can follow Nexus Medical on Twitter at @Nexus_Medical.
There is no investment information
No recent news or press coverage available for Nexus Medical.